Related Experiment Video

Updated: Jun 1, 2026

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Next generation therapies change the landscape in melanoma

Keith T Flaherty1

  • 1Massachusetts General Hospital Cancer Center 55 Fruit Street, Boston, MA 02114 USA.

F1000 Medicine Reports
|June 10, 2011
PubMed

Insights

Targeted therapies show promise for advanced melanoma. BRAF inhibitors and T-cell activating agents offer new hope for patients with this challenging cancer.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Melanoma is a significant cause of cancer-related mortality.
  • Current treatments for advanced melanoma, including chemotherapy and immunotherapy, have limited efficacy.
  • The discovery of BRAF mutations presents a potential therapeutic vulnerability.

Purpose of the Study:

  • To evaluate the efficacy of novel therapeutic strategies for advanced melanoma.
  • To explore the potential of targeting BRAF mutations and enhancing T-cell activation.

Main Methods:

  • Early phase clinical trial of a BRAF inhibitor.
  • Phase III clinical trial of a T-cell activating agent.

Main Results:

  • BRAF inhibitors demonstrate efficacy in a subset of patients.
  • Novel T-cell activating agents show significant improvements in outcomes.
  • These advancements offer new hope for treatment-refractory melanoma.

Conclusions:

  • Targeted therapies, including BRAF inhibitors and T-cell activators, are transforming melanoma treatment.
  • These novel approaches significantly improve outcomes for patients with advanced melanoma.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models05:33

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on: September 6, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...